摘要
为研究转化生长因子β3(TGF-β3)对发育期肺表面活性物质蛋白质(SPs)基因表达的影响。利用孕19天早产大鼠肺组织块及肺Ⅱ型细胞培养,检测SPs(SP-A、SP-B和SP-C)基因表达。结果:单纯使用TGF-β3对SP-A、SP-B、SP-C基因表达无明显影响,但TGF-β3可明显抑制100nmol/ml地塞米松增加SP-B、SP-C基因表达的效应,随TGF-β3浓度增加抑制显著。TGF-β3并非直接作用于肺Ⅱ型上皮细胞,而是以成纤维细胞为介导产生抑制效应。TGF-β3对地塞米松增加SP-A基因表达无影响。提示:TGF-β3对肺发育期SPs基因表达有抑制作用,糖皮质激素预防新生儿呼吸窘迫综合征效果不理想可能与TGF-β3作用有关。
To determine the effects of transforming growth factor β 3 (TGF β 3 ) on the expressions of surfactant proteins (SP), the authors employed premature rats 19 days of gestational age to detect the SP A,SP B and SP C mRNA levels in cultured lung explants and type Ⅱcells. The results of the study showed that TGF β 3 alone did not affect the expressions of SPs either in explants or in type Ⅱcells, however, TGF β 3 did significantly inhibit the increase of SP B, SP C mRNA levels by dexamethasone (100 nM) in a dose dependent manner. Furthermore, TGF β 3 had no direct inhibitory effect on the increase of SP B, SP C mRNA induced by dexamethasone in type Ⅱ cells, but by fibroblasts indirectly. The authors conclude that TGF β 3 plays an important inhibitory role in the development of pulmonary surfactant proteins and that the present study may provide a possible explanation for the unideal effects of glucocorticid in prevention of neonatal respiratory distress syndrome.
出处
《中华儿科杂志》
CSCD
北大核心
1997年第4期180-182,共3页
Chinese Journal of Pediatrics
基金
国家自然科学基金
国家教委博士点基金